Fibrosis Completed Phase 1 Trials for Belumosudil (DB16703)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03907540Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025Basic Science